title: [Personalized medicine, privatized medicine? legal and public health stakes].
abstract: Personalized medicine is booming. It tends to provide a medical management "tailored" for groups of patients, or for one unique patient, but also to identify risk groups to develop public health strategies. In this context, some radicalization phenomenon can emerge, leading to not only personalized medicine but also privatized medicine, which can lead to a capture of the medical public resource. If the "privatization" of medicine is not limited to producing adverse effects, several potentially destabilizing phenomena for patients still remain. First, some objective factors, like the adjustment of scientific prerequisites, are emerging from personalized medicine practices (clinical trial, public health policy) and are interfering with the medical doctor/patient relationship. Another risk emerges for patients concomitantly to their demand for controlling their own health, in terms of patients' security although these risks are not clearly identified and not effectively communicated. These practices, related to a privatized medicine, develop within the healthcare system but also outside, and the government and legislators will have to take into account these new dimensions in drafting their future regulations and policies.
authors.affiliation: UMR 1027 Inserm, Université de Toulouse Paul Sabatier, Toulouse, France.
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Rial-Sebbag
mesh_terms: D003695:Delivery of Health Care / Q000331:legislation & jurisprudence; D006291:Health Policy / Q000331:legislation & jurisprudence; D006295:Health Resources; D006301:Health Services Needs and Demand; D006801:Humans; D026684:Personal Autonomy; D057285:Precision Medicine; D011332:Privatization / Q000331:legislation & jurisprudence; D011634:Public Health; D011640:Public Policy / Q000331:legislation & jurisprudence; D040841:Resource Allocation; D012306:Risk